Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Background: The emergence of antifungal resistance threatens effective treatment of invasive fungal infection (IFI). Invasive candidiasis is the most common health care–associated IFI. We evaluated the activity of fluconazole (FLU) against 20 788 invasive isolates of Candida (37 species) collected from 135 medical centers in 39 countries (1997–2016). The activity of anidulafungin, caspofungin, and micafungin (MCF) was evaluated against 15 308 isolates worldwide (2006–2016). Methods: Species identification was accomplished using phenotypic (1997–2001), genotypic, and proteomic methods (2006–2016). All isolates were tested using reference methods and clinical breakpoints published in the Clinical and Laboratory Standards Institute documents. Results: A decrease in the isolation of Candida albicans and an increase in the isolation of Candida glabrata and Candida parapsilosis were observed over time. Candida glabrata was the most common non–C. albicans species detected in all geographic regions except for Latin America, where C. parapsilosis and Candida tropicalis were more common. Six Candida auris isolates were detected: 1 each in 2009, 2013, 2014, and 2015 and 2 in 2016; all were from nosocomial bloodstream infections and were FLU-resistant (R). The highest rates of FLU-R isolates were seen in C. glabrata from North America (NA; 10.6%) and in C. tropicalis from the Asia-Pacific region (9.2%). A steady increase in isolation of C. glabrata and resistance to FLU was detected over 20 years in the United States. Echinocandin-R (EC-R) ranged from 3.5% for C. glabrata to 0.1% for C. albicans and C. parapsilosis. Resistance to MCF was highest among C. glabrata (2.8%) and C. tropicalis (1.3%) from NA. Mutations on FKS hot spot (HS) regions were detected among 70 EC-R isolates (51/70 were C. glabrata). Most isolates harboring FKS HS mutations were resistant to 2 or more ECs. Conclusions: EC-R and FLU-R remain uncommon among contemporary Candida isolates; however, a slow and steady emergence of resistance to both antifungal classes was observed in C. glabrata and C. tropicalis isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Historically this organism has been pan-susceptible to triazoles, echinocandins, and amphotericin B.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although relatively low levels of resistance for most Candida species have been described, the outcomes for candidemia remain poor, as high levels of mortality (15%-50%) have been associated with candida infections7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this Review, we explore the molecular mechanisms that contribute to antifungal drug resistance, with a focus on Candida spp., the most common cause of fungal infections in humans7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Sentinel surveillance programs designed to capture organisms and patient demographic data from representative sites spanning a larger geographical area and over a longer period of time serve to fill the gaps in time and space that are necessarily left by the more intensive and focused, yet intermittent, population-bas…”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 1×
“The burden of invasive fungal infections (IFIs) for patients and health care systems is difficult to measure [2, 12]; however, it is well recognized that IFIs are associated with high morbidity and mortality rates and elevated health care costs.”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 2×
“S90 • OFID 2019:6 (Suppl 1) • Pfaller et al SENTRY Program Candida Surveillance (1997–2016) • OFID 2019:6 (Suppl 1) • S91 [93, 94], and emerging resistance mechanisms [20, 68] highlight the importance of local and global surveillance studies.”
BackgroundSelf-citationKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 1×
“Caspofungin, micafungin, and anidulafungin were approved for clinical use by the US Food and Drug Administration (FDA) in 2001, 2005, and 2006, respectively, and are now recommended as firstline agents for treating IC [50, 67].”
BackgroundCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Research works printed but not linked: 4
- 38. CLSI. M27-S4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
- 39. CLSI. M27-A3. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- 40. CLSI. M59. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
- 63. Pfaller MA, Diekema DJ Azole antifungal drug cross-resistance: mechanisms epidemiology, and clinical significance. J Invasive Fungal Infect 2007; 1: 74– 92.
Cited by
Items 801–900 of 931
Chen, J., Tian, S., Han, X., Chu, Y., Wang, Q., Zhou, B., & Shang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13226129
Chen, J., Tian, S., Han, X., Chu, Y., Wang, Q., Zhou, B., & Shang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13226123
Deep mutational scanning to study the role of epistasis in antifungal resistance.
Alexander, E. M. M. (2023) · Corpus Université Laval (Université Laval)
Evolutionary dynamics of Candida albicans in the presence and absence of antifungal drug fluconazole
Sumanarathne, A. (2024) · Mspace (University of Manitoba)
Efeito antifúngico e potencial mecanismo de ação do peptídeo PmUreβ em espécies de Candida
Perin, A. P. A. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
Pascoal, P. G. (2025) · Lume (Universidade Federal do Rio Grande do Sul)
Péter, P. (2023) · SZTE Publicatio Repozitórium (University of Szeged)
Rodrigues, D. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Schick, Y. (2024) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Rare yeast and resistance mechanisms
Hansen, A. P. (2019) · Digital Library of the University of Innsbruck (University of Innsbruck)
Bédard, C. (2023) · Corpus Université Laval (Université Laval)
Nienow, D., Ferreira, G. C., Alves, S. G., & Schütz, S. (2023) · Lume (Universidade Federal do Rio Grande do Sul)
Exploring the synergy between copper and antifungals
Gaspar‐Cordeiro, A. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zap1 is required for Candida glabrata response to fluconazole
Afonso, G. D. S. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Synthesis and Characterization of Antifungal Kinase Inhibitors and β-Lactam Antibiotics
Shirley, D. J. (2025) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/1b3r-dh22
Nosocomial infections: Epidemiology, prevention, control and Surveillance
Shahnawaz, M. D., Shahnawaz, S. S., Reza, M. T., Sharma, S., Kumar, R., & Kumar, S. (2025) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2025.28.2.3667
Malattie invasive da Candida auris
Vita, E. D., Arzilli, G., Tavoschi, L., Barnini, S., Gemignani, G., Lupetti, A., Baggiani, A., Porretta, A. D., & Rizzo, C. (2023) · CINECA IRIS Institutial research information system (University of Pisa)
Risk factor analysis associated with unfavorable treatment outcomes in invasive candidiasis
Popović, S. (2025) · National Repository of Dissertations in Serbia
Lim, S. J. (2024) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Cen, Y., Zhang, L.-L., Zhang, Z., Zhang, Y.-J., Lu, T.-X., Zhou, W.-Y., Xiang, C., Xue, Y., & Zheng, Y. (2025) · Biochemical Journal · doi:10.1042/bcj20253193
Kan Kültürlerinden İzole Edilen Candida Türlerinin Antifungal Duyarlılıklarının Değerlendirilmesi
Demırdal, T., Şen, P., Selçuk, K. A. Y. A., AKŞİT, C. A., & Gündoğdu, N. (2025) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.2025041408
Hùng, Đ. V., Quý, T. V., & Phương, T. T. (2025) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v197i12.4336
Microbial interactions: Crosstalk in the fungal mycobiome through a novel small protein
Davis, F. A., & O’Meara, T. R. (2026) · Current Biology · doi:10.1016/j.cub.2025.11.040
Belgacem, S., Chebil, W., Ferjani, I., Ghedira, D., Mastouri, M., & Babba, H. (2026) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2026.101601
Factoring fungi into the One Health conversation
Zhang, T.-Y., Lu, E.-P., Lin, Y., Zhou, J.-A., Chen, Y., Qi, W., Guo, J. F., Cheong, I. H., Wong, K. H., Kozlakidis, Z., et al. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.01.006
BARBOSA, N. T. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Silveira, M. J. C. B. (2025) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Neto, J. M. D. M. (2025) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Avaliação das atividades antioxidante e antifúngica da casca do caule de Annona squamosa L.
MACHADO, K. D. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Peixoto, P. H. S. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Κλειούση, Ε. Β. (2025) · University of Thessaly Institutional Repository (University of Thessaly)
Résistance aux antifongiques : détection, mécanismes et épidémiologie
Pasquier, G., & Charif, D. L. (2026) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(26)76541-2
Candida kefyr/Kluyveromyces marxianus infection of aortic endograft
Gómez-Barral, L., Burgoa-Rubido, B., Valverde-García, S., & Bellido, J. L. M. (2026) · Revista Española de Quimioterapia · doi:10.37201/req/118.2025
Ahmadi, A. E., Hazrati, E., Noorifard, M., Farahnejad, Z., & Mohammadimehr, M. (2026) · Iranian Journal of Microbiology · doi:10.18502/ijm.v18i1.20939
Espinoza, A. G. T., & Zevallos, A. M. U. (2025) · Universidad Peruana Cayetano Heredia Institutional Repository
Characterization of the Broad-Spectrum Antifungal NPD8193 as an Inhibitor of Cellular Trafficking
Lim, W. S. (. (2025) · TSpace (University of Toronto)
Functional Genomic Analysis of Protein Kinases in the Human Fungal Pathogen Candida albicans
Lee, Y. (2023) · TSpace (University of Toronto)
Güiza, E. M. G. (2025) · Universidad Industrial de Santander
Lackner, M., Verweij, P. E., Strauss, J., III, Rosam, K., Strobl, B., Svoboda, T., & de Jong, A. W. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2646190
Daneshnia, F. (2026) · UvA-DARE (University of Amsterdam)
Namysł, M., Skóra, M., Pomorska-Wesołowska, M., Romanik, M. K., Kwapniewska, W. Ś. –., Serwacki, P., Pawłowska, I., Olechowska‐Jarząb, A., & Wójkowska‐Mach, J. (2026) · Journal of Fungi · doi:10.3390/jof12030212
Antifungal stewardship推進を目指した抗真菌薬個別最適化投与法の確立 (本文)
サカモト, ヤ., Sakamoto, Y., & 坂本, 靖. (2021) · Institutional Repositories DataBase (IRDB)
Maqueda-Cabrera, E. E., Villavicencio, L. L. F., Villagómez-Castro, J. C., & Cuéllar‐Cruz, M. (2026) · Mycological Progress · doi:10.1007/s11557-026-02130-6
Neonatal Candidemia in Latin America: Trends, Resistance, and Prevention Strategies (2008–2025)
Guzmán, F. G. S., Rivas-Pinedo, P., & Oñate-Gutiérrez, J. M. (2026) · Journal of Fungi · doi:10.3390/jof12030230
Fongémies : épidémiologie, diagnostic et conduite à tenir
Dellière, S., Chantelot, L., Garnaud, C., & Cornet, M. (2026) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(25)48322-8
Pinheiro, M. J. F., Parker, J. E., Ferreira, M. T., Fernandes, F., & Mira, N. P. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03344-25
Bukari, A.-R. A., Sidney, B., & Gerstein, A. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.03.716392
Functional and structural studies of drug efflux by Cdr1p, an ABC transporter of Candida fungi
Pata, J. (2023) · theses.fr (ABES) · doi:10.70675/6adbc74dzad88z4878zbfc2z4a16da9e0458
Lefranc, M. (2025) · theses.fr (ABES) · doi:10.70675/23b1df92zf097z44baza610z44d1400a6905
Antifungal screening of saponins isolated from tribulus terrestris fruit extract
Lorenz, M., & Schneider, G. (2025) · International Journal of Advanced Chemistry Research · doi:10.33545/26646781.2025.v7.i12b.474
Kopczyk, M. K., Mulroney, K. T., Weaire‐Buchanan, G., Paton, T. F., Salisbury, E., Ho, W. S., Gardam, D. J., Higgins, A., Carson, C. F., Inglis, T. J. J., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1813126
Allebone-Salt, P. E., Wake, R. M., White, P. L., Price, J. S., Harrison, T., & Bicanic, T. A. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0341
Acute dacryocystitis: Microbiological profiles from an infectious diseases perspective
Koçak, F. M., & Karademir, F. P. (2026) · International Ophthalmology · doi:10.1007/s10792-026-04093-9
Inayati, I., Praseno, P., & Mustofa, M. (2026) · International Journal of Health and Pharmaceutical (IJHP) · doi:10.51601/ijhp.v6i2.618
(R)-(+)-limonene: a promising antifungal agent against Candida glabrata
Pires, B. A., Medeiros, C. I. S., Santos, J. R. D. A., Rocha, M. H. F., Lima, E. O., & Oliveira-Filho, A. A. (2026) · Brazilian Journal of Biology · doi:10.1590/1519-6984.304908
Phytochemical profiling and anticandidal potential of the marine red alga Gracilaria pudumadamensis
Rajan, P. K., Rajendran, R., Sarkar, D. D., Kolandhasamy, P., Anand, M. A. V., Lee, J., & Kim, K.-S. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100777
Efficient labeling of pathogenic fungal chitin with bioorthogonal probes
Williams, C. T., Stathoulopoulos, K. C., Blanda, C., Carnahan, B. R., & Grimes, C. L. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.05.026
Development of new type postbiotics and probiotics based on yeasts
Husová, M. (2026) · Brno University of Technology Digital Library (Brno University of Technology)
Merico, B., Chigwechokha, P. K., Alubino, P., & Bandawe, G. P. (2026) · medRxiv · doi:10.64898/2026.05.26.26354139
Kuntal, K., Singh, N., & Kumar, A. (2026) · Journal of Laboratory Physicians · doi:10.25259/jlp_345_2025
Lin, G.-L., Kuo, S., Chang, P.-H., Chen, F., & Lee, C. (2026) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2026.06.001
Dinh, V. L., Nguyen-Cong, H.-A., Tran-Ngoc, N., Duc, D.-L., Dao, N.-L., & Nguyen, B. T. (2026) · Research Square · doi:10.21203/rs.3.rs-9634179/v1
Hartl, J., Lehmann, A. D., Wahl, F., & Ralser, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731662
Avtonomova, A. V., & Краснопольская, Л. М. (2024) · Antibiot Khimioter = Antibiotics and Chemotherapy
Lee, J. Y., Baek, J. Y., Koh, H., Kim, M. S., Ahn, J. G., Ihn, K., & Kang, J. (2026) · Yonsei Medical Journal · doi:10.3349/ymj.2025.0348
توفيق, د. ا., مهدي, و. م., & ذيب, ب. ع. (2025) · Samarra Journal of Pure and Applied Science · doi:10.54153/sjpas.2025.v7i4.1103
Smâdu, S., Tetradov, S. C., Popescu, C. P., Nica, M., Oprisan, C., Ene, L., & Florescu, S. A. (2026) · Journal of Fungi · doi:10.3390/jof12070482
Gülhan, B., Kayaaslan, B., Konca, H. K., Güney, A. Y., & Coşkun, Z. N. (2026) · Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection · doi:10.5578/ced.20260206
Mıdık, E. Ö. D., Batırel, A. A., Tekol, S. D., & ASLAN, Ç. A. (2026) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.2026021598
Gülhan, B., Kayaaslan, B., Konca, H. K., Güney, A. Y., & Coşkun, Z. N. (2026) · Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection · doi:10.5578/ced.20260218
Abdel-Aty, H. F., Abdo, A. M., & Hamed, R. M. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-59895-9
Leepattarakit, T., Tulyaprawat, O., Mongkudkarn, A., & Ngamskulrungroj, P. (2026) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2026.101205
Patil, R., Mukherjee, S., Gandham, N. R., Vyawahare, C., Ajagunde, J., Nare, T., Khan, M. S., & Mukhida, S. S. (2026) · Journal of Marine Medical Society · doi:10.4103/jmms.jmms_167_25
Kumar, P., Kumari, J., & Jha, K. (2026) · International Journal of Pharmaceutical Quality Assurance · doi:10.25258/ijpqa.16.12.105
Ramírez-Trujillo, R. A., Hernández, P. C., & González, Á. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354684
Deodhar, D., Prabhakar, P. K., Busaidi, A. A., Adawi, B. A., & Balkhair, A. (2026) · Cureus · doi:10.7759/cureus.113259
Li, J., Lin, S., Liu, W., Li, P., & Luo, L. (2026) · British Journal of Biomedical Science · doi:10.3389/bjbs.2026.16761
Non-Albicans Candida Species as Opportunistic Pathogens: A Review
Sule, H., Shema, F. B., & Sharfadi, R. S. (2026) · Biological and Environmental Sciences Journal for the Tropics · doi:10.4314/bestj.v23i1.2
J-AST: a web-based analysis platform for antimicrobial susceptibility testingPreprint
Figge, M. T., Gerst, R., Mottola, A., Khatri, D., & Judith, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10449121/v1
Köklü, D., Turan, D., & Aksaray, S. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117593
Barker, K. S., Patterson, H. P., Morschhäuser, J., Wiederhold, N. P., & Rogers, P. D. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.07.047
Exploring the Genetic Diversity of Candida albicans in Animal Hosts: A One Health Perspective
re, L. A. F., Crotti, S., Giuffrè, L., Bonomo, A. L., Cruciani, D., Ranucci, A., Pernice, I., Passo, C. L., Criseo, G., & Romeo, O. (2026) · Zoonoses and Public Health · doi:10.1111/zph.70083
López‐Peralta, E., de Armentia, C., Roldán, A., Sánchez-Galiano, S., de Pipaón, M. R. P., Velasco, I. M., Lomba, M. L., Durán-Valle, M. T., Amador, P. M., González‐Romo, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.740302
Wang, H., Wang, S., Wang, K., & Cai, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-65312-y
Lao, C., Li, Z., Lin, G., Li, C., & Wang, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1905007
Gil, F., Ripani, E., Joray, M. B., del Valle, M. P., Cannon, R. D., Athanassopoulos, C. M., Vera, D. M. A., & Carpinella, M. C. (2026) · Plants · doi:10.3390/plants15162523
Sun, J., Liang, X., Song, S., Zhao, S., Zhao, X., Xinyi, D., Li, J., Jiang, F., & Kang, H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1764421
Antifungal Susceptibility Pattern of Candida species Isolated from Non-Vaginal Infection Sites
Oladejo, J. M., Ahmed, A. B., Hamzat, I., & Mustapha, A. (2026) · Sahel Journal of Life Sciences FUDMA · doi:10.33003/sajols-2026-0403-59
Yadu, R., Nawange, S. R., & Gumasta, R. (2026) · Journal of Clinical Immunology & Microbiology · doi:10.46889/jcim.2026.7207
Parallel evolution under constraint shapes echinocandin resistance in Candida aurisPreprint
Cauldron, N. C., Dort, E. N., Weeks, G., Rogers, P. D., & Cuomo, C. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.30.748140
Evolution of candidaemia and azole resistance in Italy: A multicentre retrospective study
Prigitano, A., Grancini, A., Barchiesi, F., Calabrò, M., Carletti, S., Colosimo, M., Carolis, E. D., Lupetti, A., Morroni, G., Pavan, G., et al. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05634-x
El-Atoum, M., Chen, G. L., Segal, B. H., Bonnewell, J. P., & Almyroudis, N. G. (2026) · Mycopathologia · doi:10.1007/s11046-026-01088-z
Chancharussin, N., Jitmuang, A., Chakrabarti, A., & Chayakulkeeree, M. (2026) · Mycoses · doi:10.1111/myc.70222
Jones, M. N., Nigo, M., Pérez, M. E., Casarin, S., Sanghvi, A., Jones, S. L., Corry, D. B., Arias, C. A., & Adelman, M. W. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag558
Antifungal Resistance and Development of Fungicidal Agents
Rahate, K., Dalvi, A., Chakraborty, S., & Idicula‐Thomas, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-2300-9_32-1
Entringer, T. L., & da Silveira, W. B. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05245-w
Metadata
- Authors
- Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N.
- Affiliations
- University of Iowa (US)
- The University of Adelaide (AU)
- JMI Laboratories (US)
- Corresponding author
- Pfaller, Michael A
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03
- Volume
- 6
- Issue
- Supplement_1
- Pages
- S79-S94
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC6419901
- OpenAlex
- W2922388167
- Semantic Scholar
- b99f36f4463b9afe6d2a0ab52eebb3f5e726f4c0
- Cited by
- 825
- References
- 114
- Citations by year
- 2026: 92 · 2025: 129 · 2024: 133 · 2023: 141 · 2022: 94 · 2021: 108 · 2020: 104 · 2019: 24
- FWCI
- 63.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- JMI Laboratories
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- invasive candidiasis, Candida species, antifungal resistance, fluconazole resistance, echinocandin resistance, Candida glabrata, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida auris, micafungin resistance, caspofungin, anidulafungin, Candida species distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.